An online digital health platform that integrates user-generated information with your genomic profile to give a holistic map to better health was just accepted into the
StartUp Health and
GE Healthymagination Entrepreneurship Program.
1eq, based in Georgetown, announced today that it was accepted into the three-year incubator program. While the incubator is based in New York, the company, which was cofounded by Juan Pablo Segura and Anish Sebastian, is looking at staying in D.C. for the long run.
1eq takes on the growing personal health data overload by combining information generated by online and wearable fitness tools such as run trackers, food journals, calorie counters and the like.
"The problem is on the data side," Sebastian explains. "There is information overload, a lack of understanding of that information, and no clear solutions generated by the information."
1eq combines lifestyle factors (food, exercise, weight, blood pressure, etc.) with a genome profile into "one holistic picture," Sebastian says. "We use algorithms to find trends and key information to empower consumers to live a healthier life."
Like other consumer health monitoring sites, 1eq users will create a profile on the site and upload their data from whichever device they are using. "We're platform agnostic," says Segura. Users are encouraged to obtain a DNA analysis from
23andme ($99), but it is not required for using 1eq.
Once users have set up a profile, 1eq consolidates the data they have entered and gives options for monitoring and tracking different factors over time. A personalized news feed pulls information from "research databases, medical publications, top blogs, and other sources" to keep users up to date on health conditions in their profile or for which they are at higher risk. Finally, 1eq provides what Segura calls "targeted actionable items"—real actions that users can do to lower their risk for conditions in their health profile.
"We show you what is relevant and usable on a day-to-day basis," Segura explains.
1eq will launch a public beta in July. Potential users can sign up for the beta on the company's website.